Depakote and Mesalamine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Depakote (divalproex sodium) and Mesalamine (mesalamine). Common drug interactions include adrenal insufficiency among females and atrial fibrillation among males.
The phase IV clinical study analyzes what interactions people have when they take Depakote and Mesalamine. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.
What is Depakote?
Depakote has active ingredients of divalproex sodium. It is often used in bipolar disorder. eHealthMe is studying from 55,581 Depakote users. Check the latest studies of Depakote.
What is Mesalamine?
Mesalamine has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 28,053 Mesalamine users. Check the latest studies of Mesalamine.
23 people who take Depakote and Mesalamine together, and have interactions are studied.

What are the common drug interactions of Depakote and Mesalamine, by gender? *:
female:
- Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
- Abdominal pain
- Abdominal pain upper
- Adrenocortical insufficiency acute (suddenly adrenal glands do not produce adequate amounts of steroid hormones)
- Chronic kidney disease
- Migraine (headache)
- Nausea (feeling of having an urge to vomit)
- Renal failure (kidney dysfunction)
- Osteoporosis (bones weak and more likely to break)
- Confusional state
male:
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Diarrhoea
- Dysstasia (difficulty in standing)
- Hypoglycaemia (deficiency of glucose in the bloodstream)
- Hyporesponsive to stimuli (abnormally low degree of responsiveness on an agent, action, or condition)
- Pneumonia
- Repetitive speech
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
- Tremor (trembling or shaking movements in one or more parts of your body)
- Vomiting
What are the common drug interactions of Depakote and Mesalamine, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Gastroenteritis (inflammation of stomach and intestine)
20-29:
- Abdominal pain
- Abdominal pain upper
- Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
- Adrenocortical insufficiency acute (suddenly adrenal glands do not produce adequate amounts of steroid hormones)
- Migraine (headache)
- Nausea (feeling of having an urge to vomit)
30-39:
- Diarrhoea
- Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
- Arthralgia (joint pain)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Blood lactic acid increased
- Drug ineffective
- Pain
- Pneumonia
- Vomiting
40-49:
- Body temperature increased
- Cd4 lymphocytes decreased
- Confusional state
- Dysarthria (speech disorder)
- Gait disturbance
- Insomnia (sleeplessness)
- Loss of employment
- Muscle rigidity (muscle stiffness)
- Neoplasm malignant (cancer tumour)
- Pain in extremity
50-59:
n/a
60+:
- Dysstasia (difficulty in standing)
- Hypoglycaemia (deficiency of glucose in the bloodstream)
- Hyporesponsive to stimuli (abnormally low degree of responsiveness on an agent, action, or condition)
- Repetitive speech
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
What are the existing conditions these people have? *
- Pain: 9 people, 39.13%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 17.39%
- Infection: 3 people, 13.04%
- Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 13.04%
- Mania (a state of abnormally elevated or irritable mood): 2 people, 8.70%
- Inflammatory Bowel Disease: 2 people, 8.70%
- High Blood Pressure: 2 people, 8.70%
- Blood Pressure Abnormal: 2 people, 8.70%
* Approximation only. Some reports may have incomplete information.
Do you take Depakote and Mesalamine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Depakote (55,581 reports)
- Mesalamine (28,053 reports)
Browse all drug interactions of Depakote and Mesalamine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Depakote:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Mesalamine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Depakote and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Mesalamine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .
- Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on divalproex sodium and mesalamine (the active ingredients of Depakote and Mesalamine, respectively), and Depakote and Mesalamine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Carvedilol and Oxymorphone Hydrochloride - 6 seconds ago
- Could Prograf cause Enterobacter Infection? - 9 seconds ago
- Could Venclexta cause Rash Erythematous? - 9 seconds ago
- Could Pantoprazole Sodium cause Brain Natriuretic Peptide Increased? - 9 seconds ago
- Drug interactions of Anzemet and Ibuprofen - 22 seconds ago
- Could Alprazolam cause Blood Creatinine Decreased? - 27 seconds ago
- Drug interactions of Valium and Treximet - 31 seconds ago
- Drug interactions of Restasis and Sulfamethoxazole And Trimethoprim - 31 seconds ago
- Drug interactions of Lo/Ovral and Sucralfate - 32 seconds ago
- Drug interactions of Cymbalta and Arixtra - 34 seconds ago